Nima Beheshtizadeh

Nima Beheshtizadeh

Auto-generated profile, based on publicly available information

Nima Beheshtizadeh

Department of Tissue Engineering, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NBNima Beheshtizadeh
Nima Beheshtizadeh
MGMaliheh Gharibshahian
Maliheh Gharibshahian
MBMohammad Bayati
Mohammad Bayati
RMReza Maleki
Reza Maleki
HSHannah Strachan
Hannah Strachan
LTLobat Tayebi
Lobat Tayebi
The utilization of growth factors in the process of tissue regeneration has garnered significant interest and has been the subject of extensive research. However, despite the fervent efforts invested in recent clinical trials, a considerable number of these studies have produced outcomes that are deemed unsatisfactory. It is noteworthy that the trials that have yielded the most satisfactory outcomes have exhibited a shared characteristic, namely, the existence of a mechanism for the regulated administration of growth factors. Despite the extensive exploration of drug delivery vehicles and their efficacy in delivering certain growth factors, the development of a reliable predictive approach for the delivery of delicate growth factors like Vascular Endothelial Growth Factor (VEGF) remains elusive. VEGF plays a crucial role in promoting angiogenesis; however, the administration of VEGF demands a meticulous approach as it necessitates precise localization and transportation to a specific target tissue. This process requires prolonged and sustained exposure to a low concentration of VEGF. Inaccurate administration of drugs, either through off-target effects or inadequate delivery, may heighten the risk of adverse reactions and potentially result in tumorigenesis. At present, there is a scarcity of technologies available for the accurate encapsulation of VEGF and its subsequent sustained and controlled release. The objective of this review is to present and assess diverse categories of VEGF administration mechanisms. This paper examines various systems, including polymeric, liposomal, hydrogel, inorganic, polyplexes, and microfluidic, and evaluates the appropriate dosage of VEGF for multiple applications.

1 September 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
VMVahid Mansouri
Vahid Mansouri
NBNima Beheshtizadeh
Nima Beheshtizadeh
MGMaliheh Gharibshahian
Maliheh Gharibshahian
LSLeila Sabouri
Leila Sabouri
MVMohammad Varzandeh
Mohammad Varzandeh
NRNima Rezaei
Nima Rezaei
Cancer stands as one of the most leading causes of death worldwide, while one of the most significant challenges in treating it is revealing novel alternatives to predict, diagnose, and eradicate tumor cell growth. Although various methods, such as surgery, chemotherapy, and radiation therapy, are used today to treat cancer, its mortality rate is still high due to the numerous shortcomings of each approach. Regenerative medicine field, including tissue engineering, cell therapy, gene therapy, participate in cancer treatment and development of cancer models to improve the understanding of cancer biology. The final intention is to convey fundamental and laboratory research to effective clinical treatments, from the bench to the bedside. Proper interpretation of research attempts helps to lessen the burden of treatment and illness for patients. The purpose of this review is to investigate the role of regenerative medicine in accelerating and improving cancer treatment. This study examines the capabilities of regenerative medicine in providing novel cancer treatments and the effectiveness of these treatments to clarify this path as much as possible and promote advanced future research in this field.

23 February 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MZMasoud Zarei
Masoud Zarei
MDMotahareh Shabani Dargah
Motahareh Shabani Dargah
MAMahdi Hasanzadeh Azar
Mahdi Hasanzadeh Azar
Reza AlizadehReza Alizadeh
Reza Alizadeh
FMFatemeh Sadat Mahdavi
Fatemeh Sadat Mahdavi
NBNima Beheshtizadeh
Nima Beheshtizadeh
The mechanical and biological properties of polylactic acid (PLA) need to be further improved in order to be used for bone tissue engineering (BTE). Utilizing a material extrusion technique, three-dimensional (3D) PLA-Ti6Al4V (Ti64) scaffolds with open pores and interconnected channels were successfully fabricated. In spite of the fact that the glass transition temperature of PLA increased with the addition of Ti64, the melting and crystallization temperatures as well as the thermal stability of filaments decreased slightly. However, the addition of 3–6 wt% Ti64 enhanced the mechanical properties of PLA, increasing the ultimate compressive strength and compressive modulus of PLA-3Ti64 to 49.9 MPa and 1.9 GPa, respectively. Additionally, the flowability evaluations revealed that all composite filaments met the print requirements. During the plasma treatment of scaffolds, not only was the root-mean-square (Rq) of PLA (1.8 nm) increased to 60 nm, but also its contact angle (90.4°) significantly decreased to (46.9°). FTIR analysis confirmed the higher hydrophilicity as oxygen-containing groups became more intense. By virtue of the outstanding role of plasma treatment as well as Ti64 addition, a marked improvement was observed in Wharton's jelly mesenchymal stem cell attachment, proliferation (4′,6-diamidino-2-phenylindole staining), and differentiation (Alkaline phosphatase and Alizarin Red S staining). Based on these results, it appears that the fabricated scaffolds have potential applications in BTE.

22 July 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NBNima Beheshtizadeh
Nima Beheshtizadeh
MGMaliheh Gharibshahian
Maliheh Gharibshahian
ZPZahra Pazhouhnia
Zahra Pazhouhnia
MRMohammadreza Rostami
Mohammadreza Rostami
AZAli Rajabi Zangi
Ali Rajabi Zangi
NRNima Rezaei
Nima Rezaei
The ultimate goal of regenerative medicine is to repair, regenerate, or reconstruct functional loss in failed tissues and/or organs. Although regenerative medicine is a relatively new field, multiple diverse research groups are helping regenerative medicine reach its objectives. All endeavors in this field go through in silico, in vitro, in vivo, and clinical trials which are prerequisites to translating such approaches from the bench to the bedside. However, despite such promise, there are only a few regenerative medicine approaches that have actually entered commercialization due to extensive demands for the inclusion of multiple rules, principles, and finances, to reach the market. This review covers the commercialization of regenerative medicine, including its progress (or lack thereof), processes, regulatory concerns, and immunological considerations to name just a few key areas. Also, commercially available engineered tissues, including allografts, synthetic substitutes, and 3D bioprinting inks, along with commercially available cell and gene therapeutic products, are reviewed. Clinical applications and future perspectives are stated with a clear road map for improving the regenerative medicine field.

4 December 2019 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
NBNima Beheshtizadeh
Nima Beheshtizadeh
NLNasrin Lotfibakhshaiesh
Nasrin Lotfibakhshaiesh
ZPZahra Pazhouhnia
Zahra Pazhouhnia
MHMahdieh Hoseinpour
Mahdieh Hoseinpour
MNMasoud Nafari
Masoud Nafari

28 December 2021 in Journal of Advanced Research
Verified
Journal Article
Open access
NBNima Beheshtizadeh
Nima Beheshtizadeh
MAMahmoud Azami
Mahmoud Azami
HAHossein Abbasi
Hossein Abbasi
AFAli Farzin
Ali Farzin
Tissue engineering (TE) is the main approach for stimulating the body’s mechanisms to regenerate damaged or diseased organs. Bone and cartilage tissues due to high susceptibility to trauma, tumors, and age-related disease exposures are often need for reconstruction. Investigation on the development and applications of the novel biomaterials and methods in bone tissue engineering (BTE) is of great importance to meet emerging today’s life requirements. Biphasic calcium phosphates (BCPs) offer a chemically similar biomaterial to the natural bone, which can significantly promote cell proliferation and differentiation and accelerate bone formation and reconstruction. Recent advancements in the bone scaffold fabrication have led to employing additive manufacturing (AM) methods. Extrusion-based 3D printing, known also as robocasting method, is one of the extensively used AM techniques in BTE applications. This review discusses materials and methods utilized for BCP robocasting. Recent advancements and existing challenges in the use of additives for bioink preparation are critically discussed. Commercialization and marketing approach, post-processing steps, clinical applications, in-vitro and in-vivo evaluations beside the biological responses are also reviewed. Finally, possible strategies and opportunities for the use of BCP toward injured bone regeneration are discussed.